Search | IOVS | ARVO Journals

Access Provided By:
MIT Libraries

Forgot password?

Create an Account

View

Showing 1 – 3 of 3

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2023

Safety and Efficacy of EDIT-101 for Treatment of CEP290 -associated Retinal Degeneration

Eric A Pierce; Tomas S Aleman; Bright Ashimatey; Keunpyo Kim; Rashid Rashid; Rene Myers; Mark E Pennesi

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):3785.

ARVO Annual Meeting Abstract June 2023

Twelve-month Natural History Study of CEP290- associated Retinal Degeneration

Bright Senyo Ashimatey; K. Thiran Jayasundera; Eric A Pierce; Carel C B Hoyng; Byron L Lam; Marc Dellacanonica; Keunpyo Kim; Rashid Rashid; Rene Myers; Mark E Pennesi

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):3679.

ARVO Annual Meeting Abstract June 2022

Exploratory Safety Profile of EDIT-101, a First-in-Human in vivo CRISPR Gene Editing Therapy for CEP290 -related Retinal Degeneration

Michael C Jaskolka; Saleh El-Husayni; Brian Duke; Amanda Erlwein; Rene Myers; Mark E Pennesi; Eric A Pierce; Lisa A. Michaels; Mark Shearman; Kate Zhang; Swati Mukherjee

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):2836 – A0352.

Advertisement